Cyproterone Acetate Market, By Formulation, By Application, By Geography

Description

Global Cyproterone Acetate Market is estimated to be valued at USD 342.5 Mn in 2025 and is expected to reach USD 472.7 Mn by 2032, growing at a compound annual growth rate (CAGR) of 4.7% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 342.5 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	4.70%	2032 Value Projection:	USD 472.7 Mn

Figure. Cyproterone Acetate Market Share (%), By Region 2025

Cyproterone acetate (CPA) is a progestogen and antiandrogen steroid medication that is used primarily in the treatment of prostate cancer, precocious puberty, acne, and excessive hair growth in women. It acts as a progesterone agonist or antagonist and as an antiandrogen by competing for the androgen receptor. CPA was one of the earliest clinically used antiandrogens and remains an important medication in clinical use today. It is available both as a standalone medication and in combination with an estrogen under various brand names throughout the world.

Market Dynamics:

The global cyproterone acetate market is driven by the increasing incidence of prostate cancer in men, and rising cases of acne and hirsutism in women. Moreover, shifting lifestyle patterns and growing geriatric population are major factors fueling the market growth. However, side effects associated with the long-term use of cyproterone acetate such as liver toxicity, fatigue, and depression along with the availability of alternative medications are expected to hamper market expansion to some extent. The development of conjugated forms of CPA with improved safety profiles can create lucrative opportunities over the forecast period.

Key Features of the Study:

This report provides in-depth analysis of the global cyproterone acetate market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cyproterone acetate market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Curia, Axplora, LGM Pharma, Hubei Gedian Humanwell Pharmaceutical, Cipla, NEWCHEM SPA, Swati Spentose, Teva API, Teva Pharmaceutical Industries, Unipex, Zhejiang Xianju Pharmaceutical Co. Ltd, KRKA, Cambrex, Sicor De Mexico, Zhejiang Xianju Xianle, Shaoxing Hantai Pharma, and Farmabios
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global cyproterone acetate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cyproterone acetate market

Detailed Segmentation:

Formulation Insights (Revenue, USD Mn, 2020 - 2032)
- Tablets
- Injectables
- Topical Preparations
Application Insights (Revenue, USD Mn, 2020 - 2032)
- Hormonal Replacement Therapy
- Contraception
- Acne Treatment
- Others
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Curia
- Axplora
- LGM Pharma
- Hubei Gedian Humanwell Pharmaceutical
- Cipla
- NEWCHEM SPA
- Swati Spentose
- Teva API
- Teva Pharmaceutical Industries
- Unipex
- Zhejiang Xianju Pharmaceutical Co. Ltd
- KRKA
- Cambrex
- Sicor De Mexico
- Zhejiang Xianju Xianle
- Shaoxing Hantai Pharma
- Farmabios

Product Code: CMI7287

1. RESEARCH OBJECTIVES AND ASSUMPTIONS

Research Objectives
Assumptions
Abbreviations

2. MARKET PURVIEW

Report Description
- Market Definition and Scope
Executive Summary
- Global Cyproterone Acetate Market, By Formulation
- Global Cyproterone Acetate Market, By Application

3. MARKET DYNAMICS, REGULATIONS, AND TRENDS ANALYSIS

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Cyproterone Acetate Market, By Formulation, 2025-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Injectables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Topical Preparations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Cyproterone Acetate Market, By Application, 2025-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hormonal Replacement Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Contraception
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Acne Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Cyproterone Acetate Market, By Region, 2020 - 2032, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2032, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Formulation , 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application , 2020 - 2032, Value (USD Mn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, By Formulation , 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application , 2020 - 2032, Value (USD Mn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Formulation , 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application , 2020 - 2032, Value (USD Mn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Formulation , 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application , 2020 - 2032, Value (USD Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Formulation , 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application , 2020 - 2032, Value (USD Mn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Formulation , 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application , 2020 - 2032, Value (USD Mn)
South Africa
North Africa
Central Africa

7. COMPETITIVE LANDSCAPE

Curia
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Axplora
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
LGM Pharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hubei Gedian Humanwell Pharmaceutical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cipla
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
NEWCHEM SPA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Swati Spentose
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Teva API
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Teva Pharmaceutical Industries
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Unipex
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Zhejiang Xianju Pharmaceutical Co. Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
KRKA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cambrex
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sicor De Mexico
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Zhejiang Xianju Xianle
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Shaoxing Hantai Pharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Farmabios
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

8. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

9. References and Research Methodology

References
Research Methodology
About us